Ετικέτες

Πέμπτη 17 Μαΐου 2018

Assessment of the Automated Bone Scan Index as a Biomarker of mCRPC Survival in Metastatic Prostate Cancer

This secondary analysis of a randomized clinical trial assesses the automated Bone Scan Index as an independent prognostic determinant of overall survival in men with metastatic castration-resistant prostate cancer.

https://ift.tt/2INHs4n

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου